相似文献
1
Fatal infection after rapamycin eluting coronary stent implantation.
Heart. 2005 Jun;91(6):e51. doi: 10.1136/hrt.2005.061838.
2
Mycotic pseudoaneurysm of the left circumflex coronary artery: a fatal complication following drug-eluting stent implantation.
Catheter Cardiovasc Interv. 2007 Mar 1;69(4):508-12. doi: 10.1002/ccd.21014.
3
Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
Indian Heart J. 2008 May-Jun;60(3):228-32.
4
Mycotic aneurysm of left anterior descending artery after sirolimus-eluting stent implantation: a case report.
Catheter Cardiovasc Interv. 2005 Jun;65(2):282-5. doi: 10.1002/ccd.20338.
5
Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Am J Cardiol. 2006 Apr 15;97(8):1182-7. doi: 10.1016/j.amjcard.2005.11.034. Epub 2006 Mar 9.
6
Predictors of outcome after sirolimus-eluting stent implantation for complex in-stent restenosis.
Am J Cardiol. 2005 Oct 15;96(8):1110-2. doi: 10.1016/j.amjcard.2005.06.040. Epub 2005 Aug 29.
7
Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
Diabetes Metab. 2008 Feb;34(1):62-7. doi: 10.1016/j.diabet.2007.09.002.
8
Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
J Cardiovasc Med (Hagerstown). 2008 Feb;9(2):201-4. doi: 10.2459/JCM.0b013e3281ac22b5.
9
Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Catheter Cardiovasc Interv. 2008 Apr 1;71(5):594-8. doi: 10.1002/ccd.21399.
10
Drug-eluting stents.
Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319.
引用本文的文献
1
Infective endarteritis of coronaries following percutaneous coronary intervention (stentocarditis) leading to pseudoaneurysm - a retrospective study of eleven cases.
AsiaIntervention. 2024 Jul 26;10(2):126-134. doi: 10.4244/AIJ-D-24-00010. eCollection 2024 Jul.
2
Queueing theory model of mTOR complexes' impact on Akt-mediated adipocytes response to insulin.
PLoS One. 2022 Dec 27;17(12):e0279573. doi: 10.1371/journal.pone.0279573. eCollection 2022.
3
Impact of infection in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: insight from a multicentre observational cohort from China.
BMJ Open. 2020 Sep 14;10(9):e038551. doi: 10.1136/bmjopen-2020-038551.
4
Coronary artery aneurysm formation 7 months after bare-metal stent implantation: Intravascular ultrasound and optical coherence tomography observation.
J Cardiol Cases. 2011 Feb 20;3(3):e115-e118. doi: 10.1016/j.jccase.2011.01.005. eCollection 2011 Jun.
5
Multifaceted prospects of nanocomposites for cardiovascular grafts and stents.
Int J Nanomedicine. 2015 Apr 7;10:2785-803. doi: 10.2147/IJN.S80121. eCollection 2015.
6
Coronary stent infections: a case report and literature review.
Tex Heart Inst J. 2012;39(6):884-9.
7
Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.
JACC Cardiovasc Interv. 2012 Jul;5(7):769-76. doi: 10.1016/j.jcin.2012.03.018.
8
Infectious endocarditis with systemic septic embolization as a rare complication of cardiac catheterization.
Exp Clin Cardiol. 2009 Spring;14(1):e17-20.
本文引用的文献
1
High incidence of severe infections in heart transplant recipients receiving tacrolimus.
Transplant Proc. 2003 Aug;35(5):1999-2000. doi: 10.1016/s0041-1345(03)00663-8.
2
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
N Engl J Med. 2003 Aug 28;349(9):847-58. doi: 10.1056/NEJMoa022171.
3
Coronary abscess: a complication of stenting.
Catheter Cardiovasc Interv. 2003 Jan;58(1):69-71. doi: 10.1002/ccd.10395.
4
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
N Engl J Med. 2002 Jun 6;346(23):1773-80. doi: 10.1056/NEJMoa012843.
5
Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production.
Scand J Immunol. 2001 Feb;53(2):184-91. doi: 10.1046/j.1365-3083.2001.00862.x.
6
Stentocarditis.
Circulation. 2000 May 9;101(18):E188-90. doi: 10.1161/01.cir.101.18.e188.
7
[Coronary stent implantation: infection and abscess with fatal outcome].
Z Kardiol. 1993 Aug;82(8):521-5.
Zotero 插件